Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 64,016 | 54,007 | 5,618 | -7,642 | -19,103 |
| Depreciation Amortization | 121 | 91 | 60 | 30 | 193 |
| Income taxes - deferred | 7,911 | 7,921 | N/A | N/A | N/A |
| Other Working Capital | -1,802 | -2,311 | -4,446 | -1,574 | 3,200 |
| Other Operating Activity | -79,391 | -68,387 | -8,286 | 5,667 | 7,298 |
| Operating Cash Flow | $-9,145 | $-8,679 | $-7,054 | $-3,519 | $-8,412 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,521 | 48,950 | 33,499 | 28,450 | 42,702 |
| PPE Investments | -9 | -7 | -7 | -3 | -18 |
| Purchase Of Investment | -73,886 | -73,695 | -70,821 | -4,514 | -1,307 |
| Sale Of Investment | 45,817 | 31,879 | 8,041 | 877 | 64,500 |
| Other Investing Activity | -3,000 | 0 | -1,949 | -1,194 | -60 |
| Investing Cash Flow | $5,443 | $7,127 | $-31,237 | $23,616 | $105,817 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -49,550 |
| Common Stock Repurchased | -4,741 | -732 | -371 | N/A | -2,484 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2 |
| Financing Cash Flow | $-4,741 | $-732 | $-371 | $N/A | $-52,036 |
| Exchange Rate Effect | -30 | 43 | 39 | -1 | -4 |
| Beginning Cash Position | 54,420 | 54,420 | 54,420 | 54,420 | 9,055 |
| End Cash Position | 45,947 | 52,179 | 15,797 | 74,516 | 54,420 |
| Net Cash Flow | $-8,473 | $-2,241 | $-38,623 | $20,096 | $45,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,145 | -8,679 | -7,054 | -3,519 | -8,412 |
| Capital Expenditure | -9 | -7 | -7 | -3 | -18 |
| Free Cash Flow | -9,154 | -8,686 | -7,061 | -3,522 | -8,430 |